Wockhardt Limited Wockhardt Limited

Wockhardt Limited

WOCKPHARMA

주식 순위 #4524
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical... Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine. Further, the company offers delivery devices for insulin, including Dispopen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
주가
$21.04
마지막 동기화: 2026-10-19
시가총액
$3.42B
변동 (1일)
-2.39%
변동 (1년)
34.90%
국가
IN
거래 Wockhardt Limited (WOCKPHARMA)

카테고리

Healthcare
Wockhardt Limited (WOCKPHARMA)의 주식 분할 이력
Wockhardt Limited 주식 (심볼: WOCKPHARMA)은 총 2회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Mar 08, 2022에 발생했습니다.
Apr 28, 2004 이전에 매수한 WOCKPHARMA 주식 1주는 현재 3.255주의 WOCKPHARMA 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
2022-03-08 217:200 x1.085 x3.255
2004-04-28 3:1 x3 x3
유사 기업 또는 경쟁사의 주식 분할